February 29, 2024 06:08 AM ESTUpdated 06:44 AM
Deals
Manufacturing

So­ci­etal CD­MO to be bought by an­oth­er man­u­fac­tur­er, Cor­eRx, for $1.10 a share

Anna Brown

News Reporter

Small mol­e­cule man­u­fac­tur­er So­ci­etal CD­MO will be ac­quired by drug man­u­fac­tur­er Cor­eRx for $1.10 a share, with So­ci­etal hav­ing re­cent­ly un­der­gone …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times